These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 385581)

  • 1. Activity of cefuroxime, cefoxitin and amikacin against Serratia marcesens.
    Ball P; Gray J
    J Antimicrob Chemother; 1979 Jul; 5(4):472-3. PubMed ID: 385581
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens.
    Miller MA; Yousuf M; Griffin PS; Bartlett M; Crane JK
    Microbiol Immunol; 1979; 23(10):955-64. PubMed ID: 390321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.
    Knothe H; Shah P; Krcmery V; Antal M; Mitsuhashi S
    Infection; 1983; 11(6):315-7. PubMed ID: 6321357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bactericidal kinetics of cefazolin, cefoxitin and amikacin alone and in combination (author's transl)].
    Shah PM; Stille W
    Arzneimittelforschung; 1978; 28(9):1539-41. PubMed ID: 383106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of cefoxitin and parenterally administered cephalosporins against anaerobic bacteria.
    Sutter VL; Kirby B; Finegold SM
    Rev Infect Dis; 1979; 1(1):218-23. PubMed ID: 318226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Klebsiella pneumoniae: in vitro antibacterial activity of cefoxitin and amikacin, alone and in combination.
    Yoshikawa TT
    J Antimicrob Chemother; 1979 Nov; 5(6):730-1. PubMed ID: 395157
    [No Abstract]   [Full Text] [Related]  

  • 7. The in vitro antibacterial activity of cefotaxime compared with that of cefuroxime and cefoxitin.
    King A; Warren C; Shannon K; Phillips I
    J Antimicrob Chemother; 1980 Jul; 6(4):479-94. PubMed ID: 6253433
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibacterial activity of HR-756, cefoxitin and cefuroxine against multiply antibiotic-resistant strains of Enterobacteriaceae and Pseudomonas aeruginosa.
    Legakis NJ; Kafetzis DA; Papadatos CJ; Papavassiliou JT
    Chemotherapy; 1980; 26(5):334-43. PubMed ID: 6248301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the activity of cefoperazone, cefuroxime and cefoxitin against Gram-negative bacilli and synergy studies with cefoperazone and ticarcillin.
    Miles HM; Carson M; Pavillard ER
    Drugs; 1981; 22 Suppl 1():15-9. PubMed ID: 6456885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro bactericidal action of cefoperazone, cefoxitin, cefuroxime, cefazolin and cephaloridine.
    Piantieri G; Cafarelli A; Magliulo E
    G Batteriol Virol Immunol; 1981; 74(1-6):15-25. PubMed ID: 6458524
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative staphylolytic activity of cefoxitin, cephalothin and cefuroxime.
    Rogers DT; Russell AD
    J Antimicrob Chemother; 1980 Jul; 6(4):511-7. PubMed ID: 7430014
    [No Abstract]   [Full Text] [Related]  

  • 12. Antagonism between cefoxitin and cefuroxime.
    Chattopadhyay B; Hall I
    J Antimicrob Chemother; 1979 Jul; 5(4):490-1. PubMed ID: 489501
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro susceptibility of mycobacteria species other than Mycobacterium tuberculosis to amikacin, cephalosporins and cefoxitin.
    Haas H; Michel J; Sacks TG
    Chemotherapy; 1982; 28(1):1-5. PubMed ID: 7056128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefoxitin, amikacin, and Pseudomonas aeruginosa resistance.
    Martinez-Forde JM; Garcia-Caballero J; Aguado-Matorras A
    Lancet; 1982 Sep; 2(8300):719-20. PubMed ID: 6126652
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical, epidemiologic and microbiologic features of a persistent outbreak of amikacin-resistant Serratia marcescens.
    Arroyo JC; Milligan WL; Postic B; Northey J; Parker E; Bryan CS
    Infect Control; 1981; 2(5):367-72. PubMed ID: 7028654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of third generation cephalosporins combined with amikacin against Pseudomonas aeruginosa.
    Rodríguez JR; Hernández NI; Ramírez-Ronda CH; Nevárez M
    Bol Asoc Med P R; 1985 Aug; 77(8):317-9. PubMed ID: 3931656
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of in vitro activity of cefoxitin, cefamandole, cefuroxime, and piperacillin against Chlamydia trachomatis.
    Bowie WR
    Antimicrob Agents Chemother; 1982 Feb; 21(2):339-40. PubMed ID: 6462108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential activity of bacteriocins and cefotaxime against Serratia marcescens clinical isolate SMG40 and its pigmented variant.
    Gratia JP; Crenier L
    Zentralbl Bakteriol; 1992 Feb; 276(3):340-6. PubMed ID: 1576403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of third generation cephalosporins combined with amikacin against Pseudomonas aeruginosa.
    Rodríguez JR; Hernández NI; Ramírez-Ronda CH; Nevárez M
    Bol Asoc Med P R; 1985 Jun; 77(6):242-4. PubMed ID: 3931655
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime.
    Harper PB
    Clin Ther; 1984; 6(3):310-24. PubMed ID: 6609771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.